Obsidian Therapeutics, Inc. (OBX) KPIs and segments
OBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$12.00−0.15 (-1.23%)
Close on Nov 20, 2026Market cap $741.28MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Obsidian Therapeutics's business
Coming soon
This tab will track the numbers specific to Obsidian Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?